Profile
Full Name
Castle Biosciences, Inc.Ticker Symbol
CSTLExchange
NASDAQSector
HealthcareIndustry
Diagnostics & ResearchCountry
United StatesIPO
July 25, 2019Indexes
Not includedWebsite
http://castlebiosciences.comEmployees
761Key Details
Price
$21.05(+5.83%)
Market cap
$607.19M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$332.07M(+51.09% YoY)
Annual EPS
$0.62(+128.97% YoY)
PE ratio
33.95
Next earnings date
May 2, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Castle Biosciences doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Feb 28, 25 Baird
OutperformJan 2, 25 Stephens & Co.
OverweightNov 6, 24 Scotiabank
Sector OutperformNov 5, 24 Lake Street
BuyNov 5, 24 Keybanc
OverweightNov 5, 24 Baird
OutperformOct 29, 24 Canaccord Genuity
BuyOct 14, 24 BTIG
BuyAug 6, 24 Stephens & Co.
OverweightAug 6, 24 Baird
OutperformInstitutional Ownership
- What is the ticker symbol for Castle Biosciences?
- Does Castle Biosciences pay dividends?
- What sector is Castle Biosciences in?
- What industry is Castle Biosciences in?
- What country is Castle Biosciences based in?
- When did Castle Biosciences go public?
- Is Castle Biosciences in the S&P 500?
- Is Castle Biosciences in the NASDAQ 100?
- Is Castle Biosciences in the Dow Jones?
- When was Castle Biosciences's last earnings report?
- When does Castle Biosciences report earnings?
- Should I buy Castle Biosciences stock now?
What is the ticker symbol for Castle Biosciences?
The ticker symbol for Castle Biosciences is NASDAQ:CSTL
Does Castle Biosciences pay dividends?
No, Castle Biosciences does not pay dividends
What sector is Castle Biosciences in?
Castle Biosciences is in the Healthcare sector
What industry is Castle Biosciences in?
Castle Biosciences is in the Diagnostics & Research industry
What country is Castle Biosciences based in?
Castle Biosciences is headquartered in United States
When did Castle Biosciences go public?
Castle Biosciences's initial public offering (IPO) was on July 25, 2019
Is Castle Biosciences in the S&P 500?
No, Castle Biosciences is not included in the S&P 500 index
Is Castle Biosciences in the NASDAQ 100?
No, Castle Biosciences is not included in the NASDAQ 100 index
Is Castle Biosciences in the Dow Jones?
No, Castle Biosciences is not included in the Dow Jones index
When was Castle Biosciences's last earnings report?
Castle Biosciences's most recent earnings report was on Feb 27, 2025
When does Castle Biosciences report earnings?
The next expected earnings date for Castle Biosciences is May 2, 2025
Should I buy Castle Biosciences stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions